04-28-2021 / Structural Properties of Pangolin-CoV Spike Glycoprotein Reveal Evolutionary Insight of SARS-CoV-2

04-27-2021 / The animal reservoir from SARS-CoV-2

04-26-2021 / Learn about CHO cells’ role in producing SARS-CoV-2 proteins for development of vaccines and neutralizing antibody drugs during the COVID-19 pandemic.

03-17-2021 / Learn about the central role of neutralizing antibodies to SARS-CoV-2 spike’s protein in treatment, diagnostics and evaluation of responses to infection or vaccines and how cPass has been authorized by the FDA to measure neutralizing antibodies in convale

03-09-2021 / To no one's surprise by now, SARS-CoV-2 is very efficient at infecting our lungs.

03-07-2021 / Learn about newly characterized SARS-CoV-2 variants and what scientists have learned about the efficacy of mRNA vaccines in the face of increasing viral mutations.

01-17-2021 / Selection and Attributes of Synthetic Nanobodies that Effectively Neutralize SARS-CoV-2

12-13-2020 / FDA Authorized GenScript's cPass™ Kit

12-07-2020 / When he reached his office at IAVI, once known as the International AIDS Vaccine Initiative, on the eighth floor of the Brooklyn Army Terminal, his fellow scientists wanted to know: Would they be working on a COVID-19 vaccine?